• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗癌药3,6-二氮丙啶基-2,5-双(乙氧羰基氨基)-1,4-苯醌(AZQ)对DNA的烷基化作用

Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).

作者信息

King C L, Wong S K, Loo T L

出版信息

Eur J Cancer Clin Oncol. 1984 Feb;20(2):261-4. doi: 10.1016/0277-5379(84)90193-7.

DOI:10.1016/0277-5379(84)90193-7
PMID:6538490
Abstract

The bifunctional cross-linking activity of 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ, NSC 182986) on isolated calf thymus DNA was studied, using ethidium bromide fluorescence assay. Between 1 and 350 microM AZQ produced a dose-dependent cross-linking effect in the presence of a 10-fold excess of sodium borohydride. No cross-linking was observed in the absence of the reducing agent. AZQ can also be activated by NADH and NADPH at pH 4. The AZQ cross-linking activity exhibited a strong pH dependency, highest at acidic pH, lower at alkaline pH and not seen under neutral conditions. It was also significantly inhibited under anaerobic conditions. At pH 5 the binding ratio was 1 molecule of AZQ per 191 bases at an AZQ dose of 300 microM. Our results suggest that reduced AZQ behaved like a bifunctional alkylating agent.

摘要

利用溴化乙锭荧光分析法,研究了3,6 - 二氮丙啶基 - 2,5 - 双(乙氧羰基氨基)- 1,4 - 苯醌(AZQ,NSC 182986)对分离的小牛胸腺DNA的双功能交联活性。在存在10倍过量硼氢化钠的情况下,1至350微摩尔的AZQ产生了剂量依赖性的交联效应。在没有还原剂的情况下未观察到交联现象。在pH 4时,AZQ也可被NADH和NADPH激活。AZQ交联活性表现出强烈的pH依赖性,在酸性pH下最高,在碱性pH下较低,在中性条件下则未观察到。在厌氧条件下也受到显著抑制。在pH 5时,在300微摩尔的AZQ剂量下,结合比例为每191个碱基1个AZQ分子。我们的结果表明,还原态的AZQ表现得像一种双功能烷基化剂。

相似文献

1
Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).新型抗癌药3,6-二氮丙啶基-2,5-双(乙氧羰基氨基)-1,4-苯醌(AZQ)对DNA的烷基化作用
Eur J Cancer Clin Oncol. 1984 Feb;20(2):261-4. doi: 10.1016/0277-5379(84)90193-7.
2
The reduction of anti-tumour diaziridinyl benzoquinones.
Biochim Biophys Acta. 1987 Aug 13;925(2):144-9. doi: 10.1016/0304-4165(87)90103-6.
3
Induction of DNA strand breaks and cross-links by 2,5-diaziridinyl-3,6-bis(carboethoxyamino)-1,4-benzoquinone in Chinese hamster ovary cells.2,5-二氮丙啶基-3,6-双(乙氧羰基氨基)-1,4-苯醌对中国仓鼠卵巢细胞DNA链断裂和交联的诱导作用
Cancer Res. 1984 Dec;44(12 Pt 1):5634-7.
4
DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.氮丙啶基苯醌的DNA交联作用及序列选择性:2,5-二氮丙啶基-1,4-苯醌还原后在5'-GC-3'序列处发生的独特反应。
Biochemistry. 1991 Dec 17;30(50):11719-24. doi: 10.1021/bi00114a016.
5
Mechanisms of DNA strand breakage and interstrand cross-linking by diaziridinylbenzoquinone (diaziquone) in isolated nuclei from human cells.二氮丙啶基苯醌(重氮醌)在人细胞分离细胞核中导致DNA链断裂和链间交联的机制。
Cancer Res. 1984 Oct;44(10):4453-7.
6
Cellular activation of diaziquone [2,5-diaziridinyl-3,6-bis (carboethoxyamino)-1,4-benzoquinone] to its free radical species.
Biochem Pharmacol. 1985 May 1;34(9):1449-55. doi: 10.1016/0006-2952(85)90683-5.
7
Mitochondrial toxicity of 2,5-diaziridinyl-3,6-bis-(carboethoxyamino)-1,4-benzoquinone.2,5-二氮丙啶基-3,6-双(乙氧羰基氨基)-1,4-苯醌的线粒体毒性
J Natl Cancer Inst. 1983 Oct;71(4):725-33.
8
Ability of a new antitumor agent, AZQ, to penetrate into cerebrospinal fluid.
Pharmacology. 1981;22(3):196-8. doi: 10.1159/000137490.
9
Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.经DT-黄递酶酶促还原后一系列氮丙啶基苯醌的DNA交联及序列选择性改变
Biochemistry. 1992 Mar 24;31(11):3019-25. doi: 10.1021/bi00126a025.
10
Intracerebral penetration and tissue distribution of 2,5-diaziridinyl 3,6-bis(carboethoxyamino) 1,4-benzoquinone (AZQ, NSC-182986).2,5-二氮丙啶基3,6-双(乙氧羰基氨基)-1,4-苯醌(AZQ,NSC-182986)的脑内渗透及组织分布
J Neurooncol. 1983;1(1):15-9. doi: 10.1007/BF00153636.

引用本文的文献

1
Hypoxia-targeted drug delivery.缺氧靶向药物递送。
Chem Soc Rev. 2019 Feb 4;48(3):771-813. doi: 10.1039/c8cs00304a.
2
Are reduced quinones necessarily involved in the antitumour activity of quinone drugs?还原型醌类必然参与醌类药物的抗肿瘤活性吗?
Br J Cancer Suppl. 1987 Jun;8:53-9.
3
Aziridinylbenzoquinone (AZQ) in the treatment of recurrent pediatric brain and other malignant solid tumors. A Pediatric Oncology Group phase II study.氮丙啶基苯醌(AZQ)治疗复发性小儿脑肿瘤及其他恶性实体瘤。一项儿科肿瘤学组的II期研究。
Invest New Drugs. 1990 Nov;8(4):401-6. doi: 10.1007/BF00198601.
4
In vitro activity of the novel indoloquinone EO-9 and the influence of pH on cytotoxicity.新型吲哚醌EO-9的体外活性及pH对细胞毒性的影响。
Br J Cancer. 1992 Mar;65(3):359-64. doi: 10.1038/bjc.1992.73.